Material Type

• Blood (whole) (2)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (1)
• Plasma (single spun) (3)
• Saliva (1)
• Serum (2)
• Swab medium (3)
• Urine (first morning) (1)
• Urine (random) (2)

Microscopic Assessment

• Affected (2)
• Non-affected (2)
• Not applicable (5)

Storage Temperature

• RT (1)
• -35°C to -18°C (4)
• -85°C to -60°C (3)

Associated Data

• Biomarker datasets (2)
• Clinical records (5)
• Followup records (2)
• Freezer temperature logs (4)
• Imaging data (2)
• Microbiological results (2)
• Participant Ethnicity (2)
• Physiological/biochemical measurements (1)
• Pre-analytical data (3)
• Primary care records (1)
• Quality indicators (2)
• Survey data (3)
• Treatment records (2)

Timeframe

• Immediate (5)
• 0 - 3 months (3)
• 3 - 6 months (3)
• > 6 months (3)

Participant Count

• 1 - 10 (1)
• 11 - 100 (5)
• 101 - 500 (3)
• 501 - 1000 (1)
• 1001 - 3000 (1)

Sex

• Unknown (2)
• Both sexes (7)

Age Range

• Young child (2 - 6 years) (1)
• Child (6 - 12 years) (3)
• Adolescent (12 - 18 years) (3)
• Young adult (18 - 40 years) (7)
• Adult (> 40 years) (3)
• Data not recorded (1)

Biobank Services

• Ability to recontact (1)
• Data analytics (1)
• Infectious strain isolation (2)
• Molecular Extractions (1)
• Nucleic acid extraction (2)

Collection Type

• Disease specific (9)

Consent Restriction

• No Commercial restriction (3)
• No Disease area restriction (9)
• No Genetic analysis restriction (4)
• No Human genetic analysis restriction (4)
• No restrictions (0)
• No Project specific restriction (7)
• No Scope of use restriction (9)

Collection Status

• Completed (6)
• In progress (3)

Access Condition

• Open to applicants (3)
• Open only through collaboration (3)
• Access restricted at present (2)
• Closed to access (1)

Country

• Brazil (1)
• Cameroon (1)
• France (2)
• Ghana (1)
• Kenya (1)
• Switzerland (1)
• Uganda (1)
• United Kingdom of Great Britain and Northern Ireland (1)

County